Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
$3.61M
Dr. Anatoly Dritschilo M.D.
5.00
Rockville, MD
-
-0.47
$-3.44
11.03
17.10
0.00%
-1.82
1.02
0.00
16.93
-44.09%
-52.08%
Similar stocks (6)
Catalent, Inc.
CTLT
Organogenesis Holdings Inc.
ORGO
Alimera Sciences, Inc.
ALIM
Lifecore Biomedical, Inc.
LFCR
Journey Medical Corporation
DERM
Agile Therapeutics, Inc.
AGRX
Similar stocks (6)
Catalent, Inc.
CTLT
Organogenesis Holdings Inc.
ORGO
Alimera Sciences, Inc.
ALIM
Lifecore Biomedical, Inc.
LFCR
Journey Medical Corporation
DERM
Agile Therapeutics, Inc.
AGRX